Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HCG and recombinant human FSH after varicocele repair in infertile men
IRCT201203039014N3Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- May 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label trial of human chorionic gonadotropin and recombinant human follicle stimulating hormone in male infertility and varicocele (2 arms), sponsored by Hamadan University of Medical Sciences. Primary endpoint: Improvement of semen parameters. Started May 2012; status: completed.
02
Drugs
human chorionic gonadotropinrecombinant human follicle stimulating hormone
03
Conditions
male infertilityvaricocele
Beyond the preview
Go deeper on IRCT201203039014N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201203039014N3.